NeuroBo Pharmaceuticals announced the appointment of current Board member, Hyung Heon Kim, as the company’s CEO and President, effective immediately. Kim succeeds Joseph Hooker, who served as interim CEO and President since January 2023. Prior to his appointment as CEO and President, Kim served as the General Counsel and a Senior Vice President of Dong-A ST Co, Ltd.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on NRBO:
- NeuroBo Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update
- NeuroBo Pharmaceuticals: First site IRB approval for Phase 2a trial of DA-1241
- NeuroBo Pharma enters term sheet with MThera Pharma to out-license NB-01
- NeuroBo Pharmaceuticals’ DA-1726 shows weight loss efficacy in preclinical tests
